A novel water-soluble budesonide nasal spray (Budesolv 10) improves asthmatic symptoms promptly in patients suffering from grass pollen allergic symptoms induced in an allergen exposure chamber

Authors :: Andreas Goessl
René Zieglmayer
Eva Prieschl Grassauer
Patrick Lemell
Petra Zieglmayer
Nicole Unger Manhart
Source :: Journal of Allergy and Clinical Immunology. 145:AB235
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Budesonide
business.industry
medicine.medical_treatment
Immunology
Water soluble
Nasal spray
Allergic symptoms
Grass pollen
medicine
Immunology and Allergy
In patient
ALLERGEN EXPOSURE
business
medicine.drug

Tools